Hosted on MSN
Glenmark, Alembic Pharma, Sun Pharma shares slip up to 1.5% on product recalls after USFDA action
Shares of Glenmark Pharmaceuticals, Alembic Pharmaceuticals, and Sun Pharmaceutical Industries declined up to 1.5% on Tuesday, August 19, after the US Food and Drug Administration (USFDA) reported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback